Skip to main content

Month: December 2025

Genenta Science Provides Update on CEO Ownership

MILAN and NEW YORK, Dec. 19, 2025 (GLOBE NEWSWIRE) — Genenta Science (Nasdaq: GNTA), a clinical-stage gene-therapy company developing hematopoietic stem-cell-based immunotherapies for solid tumors, provides an update regarding the ownership position of its Chief Executive Officer and Co-Founder, Pierluigi Paracchi. Over time, Mr. Paracchi has acquired 30,000 American Depositary Shares (“ADSs”) of the Company in total through open-market purchases. As reported in the Company’s filings with the U.S. Securities and Exchange Commission (“SEC”), Mr. Paracchi’s transactions in the Company’s securities have consisted of open-market purchases, with no reported sales. As calculated in accordance with SEC rules, as of December 19, 2025, Mr. Paracchi owns 2,326,129 ADSs and ordinary shares in the aggregate, representing approximately 10%...

Continue reading

Guerbet: Appointment of Mr. François Convenant as Senior Vice President of Interventional Radiology and his entry into the Executive Committee

Guerbet announces the appointment of Mr. François Convenant as Senior Vice President of Interventional Radiology and his entry into the Executive CommitteeVillepinte, December 19, 2025: GUERBET (FR0000032526 GBT), a global player in medical imaging, announces the appointment of François Convenant as Senior Vice President of Interventional Radiology.In this role, he joins the Guerbet Group’s Executive Committee (COMEX). This appointment marks an important milestone for Guerbet, confirming its leadership in the field of interventional radiology. François Convenant joined GUERBET in September 2018. He has extensive international experience in the healthcare and medical device sector. Before joining Guerbet, he held management positions at leading companies, spearheading innovation and growth projects in surgical solutions and interventional...

Continue reading

Sai Life Sciences Releases Sustainability Report 2024–25

Sai Life Sciences Sustainability Report 2024–25Sai Life Sciences Sustainability Report 2024–25HYDERABAD, India, Dec. 19, 2025 (GLOBE NEWSWIRE) — Sai Life Sciences Limited (BSE: 544306 | NSE: SAILIFE), one of India’s fastest-growing Contract Research, Development, and Manufacturing Organizations (CRDMO), today announced the release of its Sustainability Report for 2024–25. Aligned with the Global Reporting Initiative (GRI) Universal Standards 2021 and the Sustainability Accounting Standards Board (SASB) standards, this sixth edition is presented under the theme “Driving climate action, deepening stakeholder trust.” The full report can be accessed here. Commenting on the release, Krishna Kanumuri, MD & CEO, Sai Life Sciences, said: “Reliability with responsibility is central to the CRDMO mandate and deeply embedded...

Continue reading

Sampo plc’s share buybacks 18 December 2025

Sampo plc, stock exchange release, 19 December 2025 at 8:30 am EET Sampo plc’s share buybacks 18 December 2025 On 18 December 2025, Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has acquired its own A shares (ISIN code FI4000552500) as follows:                Sampo plc’s share buybacks Aggregated daily volume (in number of shares) Daily weighted average price of the purchased shares* Market (MIC Code)  4,512 10.17 AQEU    103,883 10.19 CEUX  26,668 10.18 TQEX  109,877 10.19 XHELTOTAL 244,940 10.19  * rounded to two decimals                      On 5 November 2025, Sampo announced a share buyback programme of up to a maximum of EUR 150 million in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052. The programme, which started on 6 November...

Continue reading

VALLOUREC AND GEOSTOCK SIGN A PARTNERSHIP AGREEMENT TO ACCELERATE LARGE-SCALE STORAGE SOLUTIONS FOR THE ENERGY TRANSITION

VALLOUREC AND GEOSTOCK SIGN A PARTNERSHIP AGREEMENT TO ACCELERATE LARGE-SCALE STORAGE SOLUTIONS FOR THE ENERGY TRANSITION    Meudon, December 18, 2025 – Vallourec, a world leader in premium seamless tubular solutions, and Geostock, a global specialist in underground storage of energy, have signed a Memorandum of Understanding (MoU) to strengthen their collaboration in developing the infrastructure required for the energy transition, particularly for hydrogen and carbon capture, utilization, and storage (CCUS).  This collaboration focuses especially on hydrogen storage, where the companies have a complementary product and services offering. Together, Vallourec and Geostock can support the full range of storage needs of the green hydrogen value chain. Vallourec’s turnkey Delphy storage system is capable of storing up to 100 tons of hydrogen...

Continue reading

Hepsor and Tolaram continue their cooperation in the Manufaktuuri quarter

Hepsor AS and AS Phoenix Land, a company of the Tolaram Group, signed a shareholders’ agreement on 18 December under which the parties will continue their cooperation in the implementation of the next phase of the Manufaktuuri quarter development. For this purpose, Hepsor’s subsidiary Hepsor PHX5 OÜ (registry code 17394859) has been established and is owned in equal shares by Hepsor AS and AS Phoenix Land. The new joint venture will commence the development of residential and commercial real estate in Tallinn at Manufaktuuri 3. AS Phoenix Land will contribute the property as a non-monetary contribution to the voluntary reserve capital of Hepsor PHX5 OÜ in the total amount of EUR 5.8 million. The Manufaktuuri 3 property has a valid detailed  plan. As part of the development preparation process, an architectural competition is planned with...

Continue reading

CHAGEE Releases Inaugural Sustainability Report

Modern tea house pioneer sets new industry standard through holistic sustainabilityCHAGEE Releases Inaugural Sustainability ReportCHAGEE Releases Inaugural Sustainability ReportSHANGHAI, Dec. 19, 2025 (GLOBE NEWSWIRE) — Chagee Holdings Limited (NASDAQ: CHA) (“CHAGEE” or the “Company”), a leading premium tea drinks brand serving healthy and delicious freshly-made tea drinks, recently released its inaugural Sustainability Report for 2024, marking a significant milestone in the fresh tea beverage industry’s sustainability journey. The report outlines the company’s key practices across economic, environmental, social and governance dimensions. Guided by a clear vision and accountability, the report demonstrates how CHAGEE has deeply integrated sustainability into its entire value chain — from tea gardens to...

Continue reading

Clariant announces the divestment of its business in Venezuela

AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LRClariant announces the divestment of its business in Venezuela  MUTTENZ, DECEMBER 19, 2025 Clariant, a sustainability-focused specialty chemical company, today announced that it signed and closed the divestment of its legal entity (Clariant Venezuela S.A.) in Venezuela for USD ~1.8 million (CHF ~ 1.4 million) to CMV Química, C.A., Venezuela as part of the ongoing footprint optimization. In 2024, Clariant’s operations in Venezuela generated sales of around CHF 3 million and employed around 60 people. Following the divestment of the Group’s operations in Venezuela and in accordance with IFRS, a CHF ~ 236 million cumulative translation adjustments (CTA) currently recorded as a separate component in the equity of the balance sheet (“cumulative translation reserves”), will be recycled through...

Continue reading

IBA acquires ORA expanding its strategic leadership in Nuclear Medicine

Louvain-La-Neuve, Belgium, 19 December 2025 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology with a preeminent position in nuclear medicine, acquires ORA, a global trailblazer in radiochemistry based in Belgium. This acquisition emphasizes IBA’s long-term commitment to the fast-developing and promising field of nuclear medicine. It reinforces IBA’s position at the forefront of innovation in precision oncology enabling for better diagnostic and more personalized patient therapy. The combination of IBA cyclotron leadership with ORA’s cutting-edge technology provides one of the most competitive integrated solutions for hospitals and global radiopharmacy networks looking for high productivity and access to labelling of advanced radioisotopes. This acquisition complements IBA’s existing...

Continue reading

Danish Aerospace Company A/S announces change in Certified Advisor

COMPANY ANNOUNCEMENT Odense, December19th, 2025 Company Announcement no. 75 – 19-12-2025                                 Danish Aerospace Company A/S announces change in Certified Advisor Danish Aerospace Company A/SCVR no.: DK-12 42 42 48 Danish Aerospace Company A/S (“DAC or “the company”) changes Certified Advisor in the new year due to termination of the current collaboration. As the current Certified Advisor (CA) will not be providing CA services in the future, DAC has received a termination of cooperation from Baker Tilly Corporate Finance. DAC has therefore been looking for a new Certified Advisor. The company has now appointed HC Andersen Capital, an approved certified adviser by Nasdaq First North Growth Market Denmark, as new Certified Advisor, effective January 1st, 2026. Note: This is a translation of the corresponding...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.